September 6, 2016
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
Pharmaceuticals, Biotechnology and Life Sciences
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
PureTech Health plc has announced the appointment of immunology expert and former Genzyme group vice president, Bruce L. Roberts, Ph.D., as Chief Scientific Officer.
Boston-based PureTech Health plc has launched a Scientific Advisory Board (SAB) of distinguished scientists and physicians, and the expansion of PureTech’s senior team.